With release of Rs 166 cr of incentives under PLI scheme
The DoP launched the PLI scheme for pharmaceuticals in 2025, as part of expanding the Atma Nirbharta initiative of the government. The financial outlay under this PLI scheme is Rs 15,000 crore over a period of six years. So far, 55 applicants have been selected under the scheme, including 20 micro, small, and medium enterprises (MSMEs).
India: Department Of Pharmaceuticals (DoP) Releases Final
On May 18, 2018, the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, released final guideline for implementation of provisions of the Public Procurement (Preference to Make in India) Order (PPO), 2017, with respect to public procurement of goods and services in medical devices 1.
DoP releases draft policy to catalyse R&D and innovation
Health, Pharmaceutical Policies & Reports. Recomendation of the Task Force on the Medical Devices Sector in India-2015; Satwant Reddy Report on Data Protection Provisions; Report of the Technical Expert Group on Patent Law Issues; Draft National Pharmaceuticals Policy, 2006 (Part-A) Task Force Report, 2005 under Chairmanship of Dr. Pranob Sen
DoP releases draft policy to catalyse R&D and innovation
Wednesday, October 27, 2025, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in pharmaceutical and medical devices sectors in India. The draft policy aims to encourage R&D in Pharma-MedTech sector, and promoting innovation for India to become a
Home | Department of Pharmaceuticals | Government of India
Vision To enable Indian pharmaceuticals industry to play a leading role in the global market and to ensure abundant availability, at reasonable prices within the country, of good quality pharmaceuticals of mass consumption. Celebrating Har Ghar Tiranga Dr. Mansukh Mandaviya Hon'ble Minister (C&F) Shri Bhagwanth Khuba Hon'ble Minister of State (C&F)
